Title:
mAbCL1-R2から得られる抗CD160特異的化合物の血管新生と免疫の用途
Document Type and Number:
Japanese Patent JP5162239
Kind Code:
B2
Abstract:
The present invention relates to biological and medical applications of an anti-CD160 monoclonal antibody (CL1-R2 CNCM 1-3204) and of the conservative equivalents thereof. It more particularly relates to the applications of these anti-CD 160 compounds in the fields of EC angiogenesis, and NK and T cytokine production.
More Like This:
Inventors:
Ben Susan Armand
Boom Cell Lawrence
Le Butte Philippe
Boom Cell Lawrence
Le Butte Philippe
Application Number:
JP2007525269A
Publication Date:
March 13, 2013
Filing Date:
August 09, 2005
Export Citation:
Assignee:
Insam (Institut National de la Sante d'Erchelche Medical)
International Classes:
A61K39/395; A61P3/10; A61P15/00; A61P19/02; A61P27/02; A61P29/00; A61P35/00; C07K16/28
Other References:
Proceedings of the National Academy of Sciences of the United States of America,2002年,Vol.99, No.26,p.16963-16968
Attorney, Agent or Firm:
Masayuki Masabayashi
Ryoichi Takaoka
Hayashi Ichiyoshi
Kiyoshi Kato
Ryoichi Takaoka
Hayashi Ichiyoshi
Kiyoshi Kato